Free Trial

Semler Scientific (NASDAQ:SMLR) Hits New 1-Year High - Still a Buy?

Semler Scientific logo with Medical background

Semler Scientific, Inc. (NASDAQ:SMLR - Get Free Report)'s share price hit a new 52-week high on Tuesday . The stock traded as high as $80.74 and last traded at $77.00, with a volume of 259005 shares. The stock had previously closed at $74.50.

Semler Scientific Trading Up 0.3 %

The firm has a market capitalization of $619.44 million, a price-to-earnings ratio of 36.45 and a beta of 1.18. The company has a fifty day moving average price of $44.80 and a two-hundred day moving average price of $35.13.

Semler Scientific (NASDAQ:SMLR - Get Free Report) last announced its quarterly earnings results on Monday, November 4th. The company reported $0.72 earnings per share for the quarter, beating analysts' consensus estimates of $0.37 by $0.35. Semler Scientific had a net margin of 27.00% and a return on equity of 20.31%. The business had revenue of $13.51 million during the quarter.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in the company. Principal Financial Group Inc. purchased a new stake in Semler Scientific during the 3rd quarter worth approximately $361,000. Verition Fund Management LLC purchased a new stake in shares of Semler Scientific during the third quarter worth $251,000. Shariaportfolio Inc. acquired a new stake in shares of Semler Scientific in the third quarter valued at $3,618,000. CWM LLC boosted its holdings in Semler Scientific by 486.3% in the second quarter. CWM LLC now owns 897 shares of the company's stock valued at $31,000 after purchasing an additional 744 shares during the period. Finally, Cerity Partners LLC boosted its holdings in Semler Scientific by 91.5% in the third quarter. Cerity Partners LLC now owns 1,345,586 shares of the company's stock valued at $31,689,000 after purchasing an additional 642,982 shares during the period. 49.37% of the stock is currently owned by institutional investors and hedge funds.

Semler Scientific Company Profile

(Get Free Report)

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.

Read More

Should you invest $1,000 in Semler Scientific right now?

Before you consider Semler Scientific, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Semler Scientific wasn't on the list.

While Semler Scientific currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

From Landfills to Profits: Opal Fuels CEO Shares How the Company Turns Trash into Cash
The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop
Best ETFs for 2025: Growth, Stability, and AI-Driven Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines